Sands Capital Ventures
Latest statistics and disclosures from Sands Capital Ventures's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NU, PATH, DASH, SNOW, Rayzebio, and represent 66.95% of Sands Capital Ventures's stock portfolio.
- Added to shares of these 5 stocks: Rayzebio (+$27M), KVYO (+$16M), CRWD, TOST, SNOW.
- Started 2 new stock positions in KVYO, Rayzebio.
- Reduced shares in these 2 stocks: IOT (-$15M), CFLT.
- Sands Capital Ventures was a net buyer of stock by $27M.
- Sands Capital Ventures has $338M in assets under management (AUM), dropping by -0.02%.
- Central Index Key (CIK): 0001846444
Tip: Access up to 7 years of quarterly data
Positions held by Sands Capital Ventures consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Sands Capital Ventures
Sands Capital Ventures holds 23 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Nu Hldgs Ord Shs Cl A (NU) | 19.6 | $66M | 9.2M | 7.25 |
|
|
| Uipath Cl A (PATH) | 15.5 | $53M | 3.1M | 17.11 |
|
|
| Doordash Cl A (DASH) | 14.2 | $48M | 604k | 79.47 |
|
|
| Snowflake Cl A (SNOW) | 9.8 | $33M | 216k | 152.77 |
|
|
| Rayzebio | 7.9 | $27M | NEW | 1.2M | 22.20 |
|
| Samsara Com Cl A (IOT) | 7.0 | $24M | -39% | 935k | 25.21 |
|
| 10x Genomics Cl A Com (TXG) | 5.9 | $20M | 482k | 41.25 |
|
|
| Klaviyo Class A Com (KVYO) | 4.8 | $16M | NEW | 469k | 34.50 |
|
| Acrivon Therapeutics Common Stock (ACRV) | 4.7 | $16M | 1.7M | 9.56 |
|
|
| Acumen Pharmaceuticals (ABOS) | 4.2 | $14M | 3.4M | 4.15 |
|
|
| Olink Hldg Ab Sponsored Ads (OLK) | 3.1 | $10M | 706k | 14.75 |
|
|
| Tarsus Pharmaceuticals (TARS) | 1.4 | $4.6M | 260k | 17.77 |
|
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.7 | $2.3M | 725k | 3.16 |
|
|
| Spruce Biosciences (SPRB) | 0.5 | $1.8M | 787k | 2.26 |
|
|
| 908 Devices (MASS) | 0.5 | $1.6M | 237k | 6.66 |
|
|
| Candel Therapeutics (CADL) | 0.2 | $747k | 812k | 0.92 |
|
|
| Crowdstrike Hldgs Cl A (CRWD) | 0.0 | $145k | +16% | 865.00 | 167.38 |
|
| Coupang Cl A (CPNG) | 0.0 | $143k | 8.4k | 17.00 |
|
|
| Toast Cl A (TOST) | 0.0 | $133k | +13% | 7.1k | 18.73 |
|
| Datadog Cl A Com (DDOG) | 0.0 | $124k | 1.4k | 91.09 |
|
|
| Absci Corp (ABSI) | 0.0 | $76k | 58k | 1.32 |
|
|
| Confluent Class A Com (CFLT) | 0.0 | $34k | -14% | 1.2k | 29.61 |
|
| Gitlab Class A Com (GTLB) | 0.0 | $30k | 658.00 | 45.22 |
|
Past Filings by Sands Capital Ventures
SEC 13F filings are viewable for Sands Capital Ventures going back to 2021
- Sands Capital Ventures 2023 Q3 filed Nov. 14, 2023
- Sands Capital Ventures 2023 Q2 filed Aug. 15, 2023
- Sands Capital Ventures 2023 Q1 filed May 12, 2023
- Sands Capital Ventures 2022 Q4 filed Feb. 13, 2023
- Sands Capital Ventures 2022 Q3 filed Nov. 9, 2022
- Sands Capital Ventures 2022 Q2 filed Aug. 12, 2022
- Sands Capital Ventures 2022 Q1 filed May 13, 2022
- Sands Capital Ventures 2021 Q4 filed Jan. 21, 2022
- Sands Capital Ventures 2021 Q3 restated filed Nov. 12, 2021
- Sands Capital Ventures 2021 Q3 filed Nov. 4, 2021